Knowledge check

Test your knowledge on idiopathic pulmonary fibrosis (IPF) with some quick-fire questions, get instant feedback and find out how your fellow professionals did when they took up the challenge.

References

  1. Raghu G. et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788–824.
  2. Meltzer EB. et al. Idiopathic pulmonary fibrosis. Orphanet J Rare Dis 2008;3:8.
  3. Cottin V. et al. Velcro crackles: the key for early diagnosis of idiopathic pulmonary fibrosis? Eur Respir J 2012;40:519–521.
  4. Nalysnyk L. et al. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev Off J Eur Respir Soc 2012;21:355–361.
  5. Spagnolo P. et al. Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. Multidiscip Respir Med 2012;7:42.
  6. Lamas DJ. et al. Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. Am J Respir Crit Care Med 2011;184:842–847.
  7. Song JW. et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 2011;37:356–363.
  8. CYENDIV® India pack insert version dated 10th August 2018.
  9. Richeldi L. et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 2011;365:1079–1087.
  10. Richeldi L. et al. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. N Engl J Med 2014;370:2071–2082.
  11. Richeldi L. et al. Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trials. Respir Med 2016;113:74–79.